Lithium and lecithin in tardive dyskinesia: an update.
نویسندگان
چکیده
Psychiatric inpatients with tardive dyskinesia (TD) were treated with either lithium alone (n = 9) or with a combination of lithium and lecithin (n = 9) for 5 weeks in a double-blind, placebo-controlled experiment. A statistically significant but clinically unimportant improvement of TD occurred during both treatments. The addition of lecithin to lithium had no effect.
منابع مشابه
An investigation on the relationship between risk factors and severity of tardive dyskinesia
The focus of most previous research concerning tardive dyskinesia has been on the impact of risk factors on the development( incidence) of this syndrome. In this paper, we report our results on the relationship between risk factors and the severity of tardive dyskinesia. A total of 33 patients diagnosed as tardive dyskinesia with no other medical illness studied: 21 males and 12 females with a ...
متن کاملCrocin prevents haloperidol-induced orofacial dyskinesia: possible an antioxidant mechanism
Objective(s):Long-term treatment with antipsychotics causes serious side effects such as tardive dyskinesia that characterized by abnormal movements in the orofacial region. Oxidative stress in the brain specific area is implicated in the pathophysiology of tardive dyskinesia. In this study the protective effect of crocin on haloperidol-induced orofacial dyskinesia was evaluated. Materials and ...
متن کاملA Case Study: Idiopathic Dyskinesia Treated With Choline and Lecithin
Synopsis The author reviews the use of choline and lecithin in the treatment of tardive dyskinesia. To the author's knowledge this is the first documentation of the use of choline and lecithin in the treatment of idiopathic dyskinesia. The major improvement was in the area of the dyskinetic movements, although there was some brief improvement in mentation. The encouraging results in terms of th...
متن کاملTardive dyskinesia in bipolar affective disorder: relationship to lithium therapy.
Forty patients under the age of 60 years with a DSM-III diagnosis of bipolar affective disorder were examined for the presence of tardive dyskinesia. The overall prevalence was 22.5%, with an age-related increase. Patients with and without tardive dyskinesia did not differ in terms of duration of affective illness or exposure to neuroleptics, but those patients with tardive dyskinesia had signi...
متن کاملOxidative stress and tardive dyskinesia: role of natural antioxidants
Schizophrenia is a devastating psychiatric disorder that affects 1% of population worldwide. Neuroleptics are the major class of drugs used in the treatment of schizophrenia. Neuroleptics are associated with wide variety of extrapyramidal side effects such as akathesia, dystonia, neuroleptic malignant syndrome, Parkinsonism and tardive dyskinesia. tardive dyskinesia is a complex hyperkinetic sy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Psychiatry research
دوره 19 2 شماره
صفحات -
تاریخ انتشار 1986